We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plaintiffs Tell 9th Circuit Incretin Mimetic MDL Court Got Preemption Law Wrong

(September 8, 2016, 1:05 PM EDT) -- SAN FRANCISCO — The incretin mimetic multidistrict litigation court misinterpreted U.S. Supreme Court preemption law in dismissing the MDL, plaintiffs tell the Ninth Circuit U.S. Court of Appeals in a Sept. 6 reply brief (In Re: Incretin-Based Therapies Products Liability Litigation, Jean Adams, et al. v. Merck Sharp & Dohme Corp., et al., No. 15-56997, 9th Cir.).

(Brief available. Document #28-160915-001B.)

In November, U.S. Judge Anthony J. Battaglia of the Southern District of California granted summary judgment to the defendants, finding "clear evidence" that the Food...
To view the full article, register now.